BHVN Biohaven Pharmaceutical Holding Co Ltd

Price (delayed)

$84.91

Market cap

$5.09B

P/E Ratio

N/A

Dividend/share

N/A

EPS

N/A

Enterprise value

$5.04B

Sector: Healthcare
Industry: Biotechnology

Highlights

The company's gross profit has surged by 182% QoQ
BHVN's revenue has soared by 163% QoQ
The company's quick ratio has shrunk by 67% YoY but it has surged by 57% QoQ
Biohaven Pharmaceutical Holding's net income has decreased by 28% YoY and by 28% QoQ

Key stats

What are the main financial stats of BHVN
Market
Shares outstanding
59.94M
Market cap
$5.09B
Enterprise value
$5.04B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
177.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
176.67
Earnings
Revenue
$28.51M
EBIT
-$400.34M
EBITDA
-$395.72M
Free cash flow
-$637.84M
Per share
EPS
N/A
Free cash flow per share
-$10.69
Book value per share
-$3.56
Revenue per share
$0.48
TBVPS
$12.44
Balance sheet
Total assets
$782.02M
Total liabilities
$935.83M
Debt
$264.14M
Equity
-$212.38M
Working capital
$491.17M
Liquidity
Debt to equity
-1.24
Current ratio
3.26
Quick ratio
2.88
Net debt/EBITDA
0.13
Margins
EBITDA margin
-1,387.9%
Gross margin
72.9%
Net margin
-1,439.5%
Operating margin
-1,245.4%
Efficiency
Return on assets
-78.8%
Return on equity
N/A
Return on invested capital
-482.8%
Return on capital employed
-70.9%
Return on sales
-1,404.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHVN stock price

How has the Biohaven Pharmaceutical Holding stock price performed over time
Intraday
-7.46%
1 week
-0.94%
1 month
-4.23%
1 year
64.91%
YTD
-0.93%
QTD
-0.93%

Financial performance

How have Biohaven Pharmaceutical Holding's revenue and profit performed over time
Revenue
$28.51M
Gross profit
$20.79M
Operating income
-$355.11M
Net income
-$410.44M
Gross margin
72.9%
Net margin
-1,439.5%
The company's gross profit has surged by 182% QoQ
BHVN's revenue has soared by 163% QoQ
BHVN's operating margin has surged by 52% since the previous quarter
The net margin has soared by 51% since the previous quarter

Growth

What is Biohaven Pharmaceutical Holding's growth rate over time

Valuation

What is Biohaven Pharmaceutical Holding stock price valuation
P/E
N/A
P/B
N/A
P/S
177.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
176.67
BHVN's revenue has soared by 163% QoQ

Efficiency

How efficient is Biohaven Pharmaceutical Holding business performance
The return on sales has surged by 52% since the previous quarter
BHVN's ROA is up by 13% year-on-year but it is down by 7% since the previous quarter

Dividends

What is BHVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHVN.

Financial health

How did Biohaven Pharmaceutical Holding financials performed over time
The total assets is 16% smaller than the total liabilities
BHVN's total liabilities has surged by 192% year-on-year and by 104% since the previous quarter
The total assets has surged by 84% since the previous quarter and by 78% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.